Institutional investors purchased a net $12.9 million shares of GSK during the quarter ended September 2014 and now own 11.17% of the total shares outstanding. This is a greater percentage than is typical for companies in the Pharmaceuticals: Major industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
HOTCHKIS & WILEY CAPITAL MANAGEM... Bought 5.9 Million shares of GlaxoSmithKline
INVESCO ADVISERS, INC. Bought 3.1 Million shares of GlaxoSmithKline
FIDELITY MANAGEMENT & RESEARCH C... Bought 2.9 Million shares of GlaxoSmithKline